Access to DNA sequence information on a genomic scale has enabled the design of ever-larger sets of oligonucleotides (oligos) for a wide variety of high-throughput assays. The ability to go directly from sequence information to synthetic oligos has been a cornerstone of many key advances in genomics. However, although the cost of oligo synthesis has decreased dramatically, it is still too expensive for many applications. We propose to address this major need in genomics. This Phase II proposal aims to develop a novel, inexpensive, highly flexible and efficient approach for manufacturing oligos and to demonstrate its utility in key applications in genomics.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HG004284-03
Application #
7681320
Study Section
Special Emphasis Panel (ZRG1-GGG-J (10))
Program Officer
Ozenberger, Bradley
Project Start
2007-05-21
Project End
2011-08-31
Budget Start
2009-09-01
Budget End
2011-08-31
Support Year
3
Fiscal Year
2009
Total Cost
$612,202
Indirect Cost
Name
Prognosys Biosciences, Inc.
Department
Type
DUNS #
170943737
City
San Diego
State
CA
Country
United States
Zip Code
92121
Kozlov, Igor A; Thomsen, Elliot R; Munchel, Sarah E et al. (2012) A highly scalable peptide-based assay system for proteomics. PLoS One 7:e37441